Citation: Slf. Chan, CLONIDINE-DISPLACING SUBSTANCE AND IRS PUTATIVE ROLE IN CONTROL OF INSULIN-SECRETION - A MINIREVIEW, General pharmacology, 31(4), 1998, pp. 525-529
Authors:
CHAN SLF
PALLETT AL
CLEWS J
RAMSDEN CA
CHAPMAN JC
KANE C
DUNNE MJ
MORGAN NG
Citation: Slf. Chan et al., CHARACTERIZATION OF NEW EFAROXAN DERIVATIVES FOR USE IN PURIFICATION OF IMIDAZOLINE-BINDING SITES, European journal of pharmacology, 355(1), 1998, pp. 67-76
Citation: Slf. Chan et Ng. Morgan, SIGMA-RECEPTOR LIGANDS AND IMIDAZOLINE SECRETAGOGUES MEDIATE THEIR INSULIN SECRETORY EFFECTS BY ACTIVATING DISTINCT RECEPTOR SYSTEMS IN ISOLATED ISLETS, European journal of pharmacology, 350(2-3), 1998, pp. 267-272
Citation: Slf. Chan et al., SENSITIZATION OF ISLETS TO GLUCOSE - A NEW ACTION FOR IMIDAZOLINE INSULIN SECRETAGOGUES, Diabetologia, 41, 1998, pp. 588-588
Citation: Slf. Chan et al., DIFFERENTIAL EXPRESSION OF ALPHA(2)-ADRENOCEPTOR SUBTYPES IN PURIFIEDRAT PANCREATIC-ISLET A-CELL AND B-CELL, Cellular signalling, 9(1), 1997, pp. 71-78
Citation: Slf. Chan et al., CLOTRIMAZOLE AND EFAROXAN STIMULATE INSULIN-SECRETION BY DIFFERENT MECHANISMS IN RAT PANCREATIC-ISLETS, Naunyn-Schmiedeberg's archives of pharmacology, 356(6), 1997, pp. 763-768
Authors:
CHAN SLF
PALLETT AL
CLEWS J
RAMSDEN CA
MORGAN NG
Citation: Slf. Chan et al., EVIDENCE THAT THE ABILITY OF IMIDAZOLINE COMPOUNDS TO STIMULATE INSULIN-SECRETION IS NOT DUE TO INTERACTION WITH SIGMA-RECEPTORS, European journal of pharmacology, 323(2-3), 1997, pp. 241-244
Authors:
MOURTADA M
BROWN CA
CHAN SLF
SMITH SA
PIERCY V
MORGAN NG
Citation: M. Mourtada et al., POTENTIATION OF SULFONYLUREA-INDUCED INSULIN-SECRETION BY EFAROXAN INVOLVES BLOCKADE OF ALPHA-2-ADRENOCEPTORS, Diabetologia, 40, 1997, pp. 393-393
Citation: Slf. Chan et Ng. Morgan, THE SIGMA-RECEPTOR LIGAND (-3PPP EXHIBITS IMIDAZOLINE LIKE INSULIN SECRETAGOGUE ACTIVITY IN RAT ISLETS OF LANGERHANS()), Diabetologia, 40, 1997, pp. 405-405
Citation: Slf. Chan et al., DEVELOPMENT AND CHARACTERIZATION OF POLYCLONAL ANTI-EFAROXAN ANTIBODIES FOR USE IN PURIFICATION OF ISLET IMIDAZOLINE RECEPTORS, British Journal of Pharmacology, 122, 1997, pp. 55-55
Authors:
TYACKE RJ
NUTT DJ
CHAN SLF
RAMSDEN CA
MORGAN NG
HUDSON AL
Citation: Rj. Tyacke et al., AFFINITIES OF EFAROXAN DERIVATIVES FOR ALPHA(2)-ADRENOCEPTORS AND I-2-BINDING SITES IN RAT-BRAIN MEMBRANES, British Journal of Pharmacology, 122, 1997, pp. 66-66
Citation: Ng. Morgan et al., IMIDAZOLINE-I-2 BINDING-SITES IN ADIPOSE-TISSUE - RELATIONSHIP WITH AMINE OXIDASE ACTIVITY AND GLUCOSE-METABOLISM, British Journal of Pharmacology, 122, 1997, pp. 183-183
Citation: Ng. Morgan et al., IMIDAZOLINE RECEPTORS IN THE ENDOCRINE PANCREAS - POSSIBLE THERAPEUTIC TARGETS, British Journal of Pharmacology, 122, 1997, pp. 184-184
Authors:
MOURTADA M
BROWN CA
SMITH SA
PIERCY V
CHAN SLF
MORGAN NG
Citation: M. Mourtada et al., INTERACTIONS BETWEEN IMIDAZOLINE COMPOUNDS AND SULFONYLUREAS IN THE REGULATION OF INSULIN-SECRETION, British Journal of Pharmacology, 121(4), 1997, pp. 799-805
Citation: Slf. Chan et al., THE EFFECT OF THE PUTATIVE ENDOGENOUS IMIDAZOLINE RECEPTOR-LIGAND, CLONIDINE-DISPLACING SUBSTANCE, ON INSULIN-SECRETION FROM RAT AND HUMAN ISLETS OF LANGERHANS, British Journal of Pharmacology, 120(5), 1997, pp. 926-932
Authors:
LACEY RJ
CHAN SLF
CABLE HC
JAMES RFL
PERRETT CW
SCARPELLO JHB
MORGAN NG
Citation: Rj. Lacey et al., EXPRESSION OF ALPHA(2)-ADRENOCEPTOR AND BETA-ADRENOCEPTOR SUBTYPES INHUMAN ISLETS OF LANGERHANS, Journal of Endocrinology, 148(3), 1996, pp. 531-543
Citation: Slf. Chan et Ng. Morgan, CLONIDINE-DISPLACING SUBSTANCE (CDS), AN ENDOGENOUS IMIDAZOLINE RECEPTOR-LIGAND, IS A POTENT INSULIN SECRETAGOGUE, Diabetologia, 39, 1996, pp. 107-107
Authors:
MORGAN NG
PALLETT AL
MOURTADA M
CHAN SLF
CLEWS J
RAMSDEN CA
Citation: Ng. Morgan et al., SYNTHESIS AND CHARACTERIZATION OF KU14R A NOVEL ANTAGONIST OF THE PANCREATIC-ISLET IMIDAZOLINE BINDING-SITE, Diabetologia, 39, 1996, pp. 456-456
Citation: E. Tsoli et al., THE IMIDAZOLINE I-1 RECEPTOR AGONIST, MOXONIDINE, INHIBITS INSULIN-SECRETION FROM ISOLATED RAT ISLETS OF LANGERHANS, European journal of pharmacology, 284(1-2), 1995, pp. 199-203
Citation: Slf. Chan et Ng. Morgan, MOLECULAR ANALYSIS OF ALPHA(2)-ADRENOCEPTOR GENE-EXPRESSION IN RAT PANCREATIC A-CELLS AND B-CELLS, Diabetologia, 38, 1995, pp. 130-130
Citation: Slf. Chan et al., AGMATINE, A PUTATIVE ENDOGENOUS LIGAND AT IMIDAZOLINE RECEPTORS, HAS ONLY WEAK INSULIN SECRETAGOGUE ACTIVITY, Diabetologia, 37, 1994, pp. 10000110-10000110
Citation: Slf. Chan et al., THE IMIDAZOLINE SITE INVOLVED IN CONTROL OF INSULIN-SECRETION - CHARACTERISTICS THAT DISTINGUISH IT FROM I-1-SITE AND I-2-SITE, British Journal of Pharmacology, 112(4), 1994, pp. 1065-1070
Citation: Slf. Chan, ROLE OF ALPHA-2-ADRENOCEPTORS AND IMIDAZOLINE-BINDING SITES IN THE CONTROL OF INSULIN-SECRETION, Clinical science, 85(6), 1993, pp. 671-677
Citation: Slf. Chan et Ng. Morgan, EXPRESSION OF MESSENGER-RNA FOR MULTIPLE ALPHA(2)-ADRENOCEPTOR SUBTYPES IN INSULIN-SECRETING CELLS, Diabetologia, 36, 1993, pp. 10000081-10000081
Citation: Ca. Brown et al., THE IMIDAZOLINE RX801080 ANTAGONIZES THE EFFECTS OF GLIBENCLAMIDE ANDEFAROXAN IN RAT ISLETS, Diabetologia, 36, 1993, pp. 10000104-10000104